News & Updates

2-dose, 3-dose vax schedules active against several meningococcal serogroup B strains
2-dose, 3-dose vax schedules active against several meningococcal serogroup B strains
25 May 2023 byJairia Dela Cruz

Both the 2-dose and 3-dose vaccination schedules of the four-component meningococcal serogroup B vaccine (4CMenB) appear to provide protection against a panel epidemiologically relevant strains in adolescents and young adults, according to a phase III study presented at ESPID 2023.

2-dose, 3-dose vax schedules active against several meningococcal serogroup B strains
25 May 2023
Fibromyalgia symptoms weakly predict RA activity after treatment
Fibromyalgia symptoms weakly predict RA activity after treatment
24 May 2023

Higher levels of fibromyalgia (FM) symptoms in patients with rheumatoid arthritis (RA) are slightly indicative of worse disease activity following treatment with a disease-modifying antirheumatic drug (DMARD), suggest the results a recent study.

Fibromyalgia symptoms weakly predict RA activity after treatment
24 May 2023
Sarcoidosis not uncommon in systemic sclerosis
Sarcoidosis not uncommon in systemic sclerosis
23 May 2023

The occurrence of sarcoidosis in patients with systemic sclerosis (SSc) is rare but seems to be more frequent when compared to the general population, reveals a study.

Sarcoidosis not uncommon in systemic sclerosis
23 May 2023